Ferrosan
Part of Pfizer
CompanyDenmark
Ferrosan develops one asset, in phase 3, no development reported (glucosamine in back pain). Mostly small molecule; based in Denmark.
- 1
- Asset
- Furthest stage
- Phase 3, no development reported
- 1
- Trial
- 3
- Signals
Pipeline
1Supports cartilage matrix synthesis and maintenance.
Phase 3, no development reported, Small molecule, back pain, knee osteoarthritis
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials2
- Signals17
- Similar companies6